BioReliance has tapped John Kolman to take over as senior director of research and development. Kolman formerly worked at Invitrogen as principal scientist on the HLA Single Antigen Initiative and lung cancer biomarker programs. He also studied DNA replication initiation at the Salk Institute.
Claire Fraser-Ligget and Steven St. Peter will not stand for re-election as directors of Helicos Biosciences at the company’s upcoming May stockholder’s meeting, according to a filing with the US Securities and Exchange Commission.
Until the annual meeting, St. Peter will continue as a member of the Nominating and Corporate Governance Committee and Fraser-Liggett will continue to serve as a member of the Compensation Committee
Helicos said that neither of the individuals made their decision due to any disagreement with the company.